PathAI, Bristol Meyers Squibb: Evolving strategic relationship will drive the use of artificial intelligence (AI)-powered pathology in translational research and clinical trials BOSTON — August 25, 2022 — PathAI, a global leader in...

PharmaNest, an emerging leader in quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest continuous score for the quantification of the severity of fibrosis and treatment effects of...

AI and manual pathology measurements show efficacy of semaglutide over placebo in phase 2 clinical trial, with AI continuous scoring providing quantitative insight into histological changes Boston, Massachusetts - PathAI, a global leader of...

Designed to aid pathologists in the clinical diagnosis of liver fibrosis and other chronic liver diseases, the stain-free Laennec® digital pathology imaging system by MedTech innovator Histoindex Pte. Ltd. has achieved its first regulated...